SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-015705
Filing Date
2024-05-09
Accepted
2024-05-09 16:34:15
Documents
78
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q zvra20240331_10q.htm   iXBRL 10-Q 1177590
2 EXHIBIT 10.1 ex_670175.htm EX-10.1 862534
3 EXHIBIT 31.1 ex_649814.htm EX-31.1 13770
4 EXHIBIT 31.2 ex_649815.htm EX-31.2 13971
5 EXHIBIT 32.1 ex_649816.htm EX-32.1 7010
6 EXHIBIT 32.2 ex_649817.htm EX-32.2 7286
  Complete submission text file 0001437749-24-015705.txt   7772969

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA zvra-20240331.xsd EX-101.SCH 69394
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE zvra-20240331_cal.xml EX-101.CAL 63220
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE zvra-20240331_def.xml EX-101.DEF 459220
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE zvra-20240331_lab.xml EX-101.LAB 426339
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE zvra-20240331_pre.xml EX-101.PRE 493992
82 EXTRACTED XBRL INSTANCE DOCUMENT zvra20240331_10q_htm.xml XML 965640
Mailing Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747
Business Address 1180 CELEBRATION BOULEVARD, SUITE 103 CELEBRATION FL 34747 (321) 939-3416
ZEVRA THERAPEUTICS, INC. (Filer) CIK: 0001434647 (see all company filings)

IRS No.: 205894398 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36913 | Film No.: 24931331
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)